2008. ISPOR European Congress – Rufinamide in the Adjunctive Treatment of Lennox-Gastaut Syndrome (LGS): A Cost Effectiveness Analysis.

Yi Y, Verdian L, Jansen JP. Rufinamide in the Adjunctive Treatment of Lennox-Gastaut Syndrome (LGS): A Cost Effectiveness Analysis. Value Health. 2008 Nov;11(6):A605. Presented at: ISPOR 11th Annual European Congress; November 11, 2008; Athens, Greece.